论文信息 - Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study - 字舞流文

Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study

G. Shapiro | I. Braña | B. Pistilli | D. Castellano | V. Alfaro | C. Kahatt | V. Subbiah | V. Boni | J. Trigo | K. Zaman | M. Siguero | A. Zeaiter | A. Anton | G. Huidobro | C. Fernandez | V. Moreno | F. Longo | A. Paredes